ATE371439T1 - Granulat bestehend aus stärke und laktose - Google Patents

Granulat bestehend aus stärke und laktose

Info

Publication number
ATE371439T1
ATE371439T1 AT00402159T AT00402159T ATE371439T1 AT E371439 T1 ATE371439 T1 AT E371439T1 AT 00402159 T AT00402159 T AT 00402159T AT 00402159 T AT00402159 T AT 00402159T AT E371439 T1 ATE371439 T1 AT E371439T1
Authority
AT
Austria
Prior art keywords
starch
lactose
granules consisting
granules
test
Prior art date
Application number
AT00402159T
Other languages
English (en)
Inventor
Oliver Luhn
Original Assignee
Roquette Freres
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roquette Freres filed Critical Roquette Freres
Application granted granted Critical
Publication of ATE371439T1 publication Critical patent/ATE371439T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2991—Coated

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Glanulating (AREA)
  • Grain Derivatives (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT00402159T 2000-07-27 2000-07-27 Granulat bestehend aus stärke und laktose ATE371439T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00402159A EP1175899B1 (de) 2000-07-27 2000-07-27 Granulat bestehend aus Stärke und Laktose

Publications (1)

Publication Number Publication Date
ATE371439T1 true ATE371439T1 (de) 2007-09-15

Family

ID=8173789

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00402159T ATE371439T1 (de) 2000-07-27 2000-07-27 Granulat bestehend aus stärke und laktose

Country Status (23)

Country Link
US (1) US6770368B2 (de)
EP (1) EP1175899B1 (de)
JP (1) JP4394313B2 (de)
KR (1) KR100869171B1 (de)
CN (1) CN1253148C (de)
AT (1) ATE371439T1 (de)
AU (1) AU785135B2 (de)
BR (1) BR0107036A (de)
CA (1) CA2353363C (de)
CZ (1) CZ303682B6 (de)
DE (1) DE60036205T2 (de)
ES (1) ES2292414T3 (de)
HU (1) HU229277B1 (de)
IL (1) IL148752A0 (de)
MX (1) MXPA01007666A (de)
NO (1) NO333750B1 (de)
NZ (1) NZ517931A (de)
PL (1) PL203778B1 (de)
RS (1) RS49931B (de)
RU (1) RU2286142C2 (de)
SK (1) SK286951B6 (de)
WO (1) WO2002009673A1 (de)
ZA (1) ZA200202178B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2826549A1 (fr) * 2001-06-28 2003-01-03 Roquette Freres Procede de preparation d'un comprime edulcorant et comprime edulcorant ainsi obtenu.
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible
FR2834894B1 (fr) * 2002-01-21 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de piribedil
FR2834896B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'ivabradine
FR2834893B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de perindopril
FR2834897B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de testosterone
FR2834890B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible d'agomelatine
FR2834892B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de mitiglinide
FR2834891B1 (fr) * 2002-01-23 2004-02-27 Servier Lab Composition pharmaceutique orodispersible de 2-({2-methoxy-2-[3(trifluoromethyl)phenyl]ethyl}amino)ethyl4 -(2-(9h-fluoren-9-yl)acetyl]amino}ethyl)benzoate
US20030228370A1 (en) * 2002-06-11 2003-12-11 Michel Serpelloni Orodispersible solid pharmaceutical form
FR2857593B1 (fr) * 2003-07-18 2005-10-14 Servier Lab Composition pharmaceutique orodispersible d'un compose antithrombotique
GB0329208D0 (en) * 2003-12-17 2004-01-21 Ici Plc Particulate materials
GB0523810D0 (en) * 2005-11-23 2006-01-04 Astrazeneca Ab Pharmaceutical compositions
FR2894475B1 (fr) * 2005-12-14 2008-05-16 Servier Lab Composition pharmaceutique orodispersible pour administra- -tion oromucosale ou sublinguale d'agomelatine
CA2672134C (en) * 2006-12-07 2015-02-10 Daiichi Sankyo Company, Limited Solid medicinal preparation containing mannitol or lactose
JPWO2008069262A1 (ja) * 2006-12-07 2010-03-25 第一三共株式会社 安定性が改善されたフィルムコーティング製剤
US9034860B2 (en) * 2006-12-07 2015-05-19 Daiichi Sankyo Company, Limited Pharmaceutical composition containing low-substituted hydroxypropyl cellulose
CN101600431B (zh) * 2006-12-07 2011-09-07 第一三共株式会社 具有改进贮存稳定性的药物组合物
FR2933299B1 (fr) 2008-07-04 2012-02-03 Roquette Freres Mannitol orodispersible
DE102008047910A1 (de) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tablettierhilfsstoff auf Laktose- und Cellulosebasis
JP5637624B2 (ja) * 2009-02-12 2014-12-10 富士化学工業株式会社 崩壊性粒子組成物及びそれを用いた速崩壊性圧縮成型物
FR2944971B1 (fr) * 2009-04-30 2012-09-07 Roquette Freres Coagglomerats de mannitol et d'amidon granulaire comprimables et a ecoulement libre
US20130071456A1 (en) * 2010-06-23 2013-03-21 Colgate-Palmolive Company Encapsulation of ingredients in lactose matrix to form active encapsulates
FR2966828B1 (fr) * 2010-11-02 2012-12-28 Roquette Freres Poudre de polysaccharide et de polyol, comprimable et de haute viscosite
JP5483482B2 (ja) 2011-05-23 2014-05-07 三井製糖株式会社 糖液から固形物を製造する方法及び固形物
CN102516321A (zh) * 2011-12-08 2012-06-27 上海天伟生物制药有限公司 一种药用乳糖及其制备方法和用途
JP5276199B1 (ja) * 2012-03-23 2013-08-28 池田食研株式会社 多孔質顆粒の製造方法
US9522964B2 (en) * 2012-04-03 2016-12-20 Development, Inc. Micronized starch and methods for manufacturing same
US20170208849A1 (en) 2014-07-21 2017-07-27 Roquette Freres Sugar compositions for tableting by direct compression
EP3002005A1 (de) 2014-09-30 2016-04-06 Molkerei Meggle Wasserburg GmbH & Co. Kg Direktkomprimierter Hilfsstoff auf Basis von Lactose, Cellulose und Stärke
EP3034070A1 (de) * 2014-12-18 2016-06-22 Omya International AG Verfahren zur Herstellung eines pharmazeutischen Abgabesystems
JP6544564B2 (ja) * 2015-04-20 2019-07-17 清水建設株式会社 模擬粉体、及び粉体飛散状態評価方法
US10820608B1 (en) 2015-10-26 2020-11-03 The Hershey Company Hard candy confections with low hygroscopicity
US11433053B2 (en) 2017-01-24 2022-09-06 Medshine Discovery Inc. LSD1 inhibitor and preparation method and application thereof
EP4687846A1 (de) 2023-03-28 2026-02-11 RUPP, Thomas Verfahren zur herstellung eines granulats und eines granulats, insbesondere einer hilfsstoffgranulatverbindung

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE575343A (de) * 1955-09-09
AT376147B (de) * 1980-12-15 1984-10-10 Gergely Gerhard Verfahren und vorrichtung zum granulieren eines pulvergemisches
DE3505433A1 (de) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen Direkttablettierhilfsmittel
US5043170A (en) * 1989-02-14 1991-08-27 Hoffmann-La Roche Inc. Animal feed composition containing a vitamin D metabolite
JPH0584054A (ja) * 1991-09-27 1993-04-06 Kunoole Shokuhin Kk スープまたはソース粉末もしくは顆粒の製造法
JP3349535B2 (ja) * 1993-01-12 2002-11-25 フロイント産業株式会社 球形顆粒の製造方法
JPH08298956A (ja) * 1995-05-10 1996-11-19 Ajinomoto Co Inc 顆粒状調味料の製造方法
JPH0937737A (ja) * 1995-05-25 1997-02-10 Tokiwa Kanpo Seiyaku:Kk 菊花含有健康食品
JP3611652B2 (ja) * 1995-10-30 2005-01-19 長谷川香料株式会社 コーティング粉末の製造方法
DE19603984A1 (de) * 1996-02-05 1997-08-07 Bayer Ag Granulate von Triazinen
JP4064476B2 (ja) * 1996-03-29 2008-03-19 エラワン ファーマスーティカル リサーチ アンドラボラトリー カンパニー リミテッド 二酸化珪素を有する球状凝集した澱粉
JP3934179B2 (ja) * 1996-07-11 2007-06-20 不二製油株式会社 動物の体内へ摂取される物質からなる粉体を造粒する方法及び造粒物
RU2363469C2 (ru) * 1996-12-24 2009-08-10 Федеральное Государственное Унитарное Предприятие Государственный Научно-Исследовательский Институт "Биоэффект" (Фгуп Гнии "Биоэффект") Состав для капсул
JP3447042B2 (ja) * 1997-07-23 2003-09-16 フロイント産業株式会社 単一物質球形粒の製造方法

Also Published As

Publication number Publication date
IL148752A0 (en) 2002-09-12
DE60036205T2 (de) 2008-05-21
SK3702002A3 (en) 2002-08-06
US20020035248A1 (en) 2002-03-21
BR0107036A (pt) 2002-06-04
EP1175899B1 (de) 2007-08-29
MXPA01007666A (es) 2004-08-11
CN1386064A (zh) 2002-12-18
YU22002A (sh) 2004-09-03
CZ2002978A3 (cs) 2002-06-12
CZ303682B6 (cs) 2013-03-06
JP2002142690A (ja) 2002-05-21
WO2002009673A1 (fr) 2002-02-07
HU229277B1 (en) 2013-10-28
NO20021424D0 (no) 2002-03-21
PL353056A1 (en) 2003-10-06
RS49931B (sr) 2008-09-29
US6770368B2 (en) 2004-08-03
KR100869171B1 (ko) 2008-11-19
NO20021424L (no) 2002-03-21
RU2286142C2 (ru) 2006-10-27
CN1253148C (zh) 2006-04-26
KR20020063868A (ko) 2002-08-05
CA2353363C (fr) 2010-06-01
PL203778B1 (pl) 2009-11-30
AU785135B2 (en) 2006-10-05
EP1175899A1 (de) 2002-01-30
SK286951B6 (sk) 2009-08-06
DE60036205D1 (de) 2007-10-11
RU2002111360A (ru) 2004-01-10
ZA200202178B (en) 2003-06-05
ES2292414T3 (es) 2008-03-16
CA2353363A1 (fr) 2002-01-27
NZ517931A (en) 2003-11-28
NO333750B1 (no) 2013-09-09
AU7990901A (en) 2002-02-13
JP4394313B2 (ja) 2010-01-06
HUP0203064A2 (en) 2003-03-28

Similar Documents

Publication Publication Date Title
DE60036205D1 (de) Granulat bestehend aus Stärke und Laktose
IS2788B (is) Búdesóníð- / formóterólefnablanda til innöndunar með lausa þéttni frá 0,30 til 0,36 g/ml, aðferð við að framleiða efnablönduna og notkun hennar
ITRM920476A0 (it) Formulazioni galeniche contenenti ciclosporina.
WO2002098856A3 (en) Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists
WO2001032646A3 (en) Sulfonamide derivatives
BG103930A (en) Eletriptan hemisulphate and caffeine containing pharmaceutical compositions
DK254787D0 (da) Farmaceutiske praeparater til behandling af sygdomme foraarsaget af oxidativt stress og indeholdende 2-phenyl.1,2-benziso-selenazol-3(2h)-on som aktiv bestanddel
DK0929234T3 (da) Tabletter indeholdende en sødemiddelblanding
NO20012249L (no) Faststoffsammensetning inneholdende D-mannitol og cerivastatin samt anvendelse av faststoffsammensetning forfremstilling av farmasöytisk preparat
NO302368B1 (no) Kinoksalinforbindelser, farmasöytiske preparater som inneholder slike, og anvendelse av forbindelsene for fremstilling av preparatene
NO995431D0 (no) Substituerte 3,3-diamino-2-propennitriler, deres fremstilling og anvendelse
CA2268399A1 (en) Anti-neurogenic inflammatory compounds and compositions and methods of use thereof
CA2442210A1 (en) Aryl oxime-piperazines useful as ccr5 antagonists
AP2001002369A0 (en) Pharmaceutical complex.
WO2000058328A3 (de) Avermectinderivate
RU2001135343A (ru) Штамм бактерий Bifidobacterium longum 58B для приготовления биологически активных добавок, регулирующих микрофлору кишечника у детей раннего возраста
NO923266D0 (no) Heksahydrobenzo(f)quinolinoner
MX9202432A (es) Compuestos de 4,5-dihidro-1,4-benzotiazepin-3(2h)onas, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
NO20021429L (no) 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner
BG102638A (bg) Таблети с високо съдържание на фамцикловир
DE60219578D1 (de) Antipyretisches Präparat enhaltend Xylitol
NO20054086L (no) Depigmenteringsmidler
SE9803280D0 (sv) Novel compounds
WO2001090085A3 (de) 6-methyl-4-trihalogenmethyltriazinverbindungen
SE9803277D0 (sv) Novel compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties